Filter announcements
Loading...
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
Aurobindo Pharma has announced a board meeting to discuss its financial results for the quarter and nine months ended December 31, 2024. The company's revenue from operations for this period reached ₹82,013.1 crore, an increase compared to ₹77,516.1 crore in the previous nine months. Profit before tax stood at ₹18,029.3...